**Core tip:** Although colonoscopy-related adverse events rarely occur and the need for colonoscopy is increasing, the proportion of subjects with risk factors is increasing. Recently, the perforation rate, as reported in large studies, ranges from 0.005-0.085%. The perforation probability after colonoscopy does not decrease over time in either the West or the East. Other studies have reported post-colonoscopy bleeding occurring in 0.001-0.687% of cases. In this review article, we discuss the current trends in post-colonoscopy complications, as well as the challenges to be addressed through future research.

INTRODUCTION
============

Colonoscopy is a widely used method for diagnosing and treating colonic disease. As colorectal cancer (CRC) screenings and surveillance increase worldwide, the number of colonoscopies required is also steadily increasing\[[@B1]\]. In addition, the number of colonoscopies is also mounting in both patients with comorbidities as well as elderly patients due to increasing life expectancy\[[@B2]-[@B4]\]. Although colonoscopy-related adverse events rarely occur, the need for colonoscopy is increasing. As the proportion of subjects with risk factors increases, it is essential to identify and reduce these adverse events\[[@B5]\].

Recently proposed colonoscopy quality indicators have suggested appropriate performance targets for adverse events. According to the American Society for Gastrointestinal Endoscopy (ASGE)/American College of Gastroenterology Task Force on Quality in Endoscopy, post-polypectomy bleeding occurs in \< 1% of cases\[[@B6]\]. The incidence of perforations is \< 1:500 for all examinations and \< 1:1000 for screenings\[[@B6]\]. The European Society of Gastrointestinal Endoscopy (ESGE) also recommends appropriate rates for colonoscopy-related adverse events. ESGE proposed a rate of \< 5% for bleeding and \< 1:1000 for perforations\[[@B7]\]. However, the proportion of adverse events associated with colonoscopy varies widely in practice. The incidence rate of adverse events changes according to the characteristics of the patient or the endoscopist, the type of procedure, and time trends\[[@B5],[@B8]-[@B10]\].

Detecting neoplastic lesions during a colonoscopy prevents CRC\[[@B11]\]. For this reason, the role of colonoscopy in population screening tests (even in asymptomatic and previously healthy populations) is becoming increasingly important. It therefore must be recognized that colonoscopy-related adverse events could even be harmful to healthy people. In particular, complications, such as perforations or massive bleeding, may seriously affect the patient. It is therefore important to know exactly how the adverse event occurs in actual clinical practice and how it develops. Based on recent large-scale studies, this review will discuss trends in the occurrence of adverse events (perforation, bleeding, and others) related to colonoscopy, regional differences, and oversight of complications at the national level.

PERFORATION TIME TRENDS AND REGIONAL DIFFERENCES
================================================

A colon perforation is a well-known adverse event resulting from colonoscopy. It happens very rarely, but it is a feared adverse event with high morbidity and considerable mortality\[[@B12],[@B13]\]. Generally, colonoscopy perforation was defined as intraperitoneal fat or viscera seen during the colonoscopy, or the presence of radiographic abnormalities (intra-abdominal free air on X-rays, or localized or diffuse release of gas or intestinal fluid into the peritoneum on computed tomography (CT) scans)\[[@B5],[@B9],[@B14]\]. Colonoscopy perforations may occur by several mechanisms, such as mechanical trauma, barotrauma, thermal energy and removal of a tissue lesion\[[@B14]\]. Iqbal et al\[[@B13]\] classified the injury characteristics, based on the mechanism of perforation, into thermal, polypectomy and blunt. Blunt injury is caused by direct trauma or torque from the endoscope; this mechanism results in the largest perforations. The cecum is the most frequent site of perforation due to thermal energy and polypectomy, as well as the rectosigmoid colon due to blunt injuries\[[@B13]\]. The outcome varies depending on the type of perforation. In particular, blunt injuries have larger perforations and a higher rate of fecal diversion than polypectomy injury and, therefore, a worse prognosis\[[@B13]\]. In addition, immediate detection of perforation results in less intraperitoneal contamination than delayed detection. In general, perforations detected during or immediately after colonoscopy have a better prognosis than those whose detection is delayed, and less frequently require surgical treatment\[[@B8],[@B13],[@B15]\]. In totality, the recto-sigmoid colon has emerged as the most frequent site of perforation\[[@B13]\]. Bielawska et al\[[@B16]\] demonstrated that increasing age, increasing American Society of Anesthesia (ASA) class, female gender, hospital setting, therapeutic colonoscopy and removing polyps \> 10 mm are factors significantly associated with an increased risk of early perforation. In particular, perforations in elderly patients can lead to a high proportion of fatal consequences. Therefore, endoscopists should keep in mind that colonoscopy can be a major drawback to these patients\[[@B16],[@B17]\].

Surgery plays an important role in the treatment of post-colonoscopy perforation. Recent advances in endoscopic techniques have enabled treatment of \< 10 mm immediately detected colonoscopyrelated perforations in patients with good bowel preparation and stable vital signs\[[@B18]\]. The ESGE recommends the use of through-the-scope endoclips for small perforations and over-the-scope clips (OTSC) for larger ones\[[@B19]\]. In addition, electrocautery injury may induce colon perforations, which can be closed by endoscopic clipping, particularly during endoscopic submucosal dissection (ESD)\[[@B20],[@B21]\]. According to systematic reviews, the OTSC method is effective for treating diagnostic and therapeutic colon perforations\[[@B22],[@B23]\]. Furthermore, endoscopic band ligation is a salvage technique for the treatment of iatrogenic colonic perforation after failure of endo-clipping\[[@B24]\].

Large-scale studies about colonoscopy perforations were less reported before 2000. Araghizadeh et al\[[@B25]\] showed that 31 perforations occurred in 34,620 colonoscopies (0.09%) over 30 years. Two other studies also showed that the overall rate of perforation is \< 0.1%\[[@B26],[@B27]\]. However, another large population-based cohort study demonstrated 108 perforations after 39,286 colonoscopies (0.20%), and reported that the risk of perforation during a colonoscopy is roughly double compared with sigmoidoscopy\[[@B28]\]. Many large-scale studies on colonoscopy perforations have been published since 2000. In particular, recent studies have assessed the occurrence of colonoscopy perforations using big data analyses\[[@B16],[@B29],[@B30]\]. A large study based on comprehensive French health insurance data, which included nearly one million colonoscopies, suggested that the estimated perforation rate was 0.04% (424/947,061)\[[@B29]\]. That study indicated that a patient's elderly status, resecting a large polyp (\> 10 mm), and emergency colonoscopy are associated with a risk of perforation. Another study also reported similar perforation rates, such as 0.02% (192/1,144,900)\[[@B16]\]. Pox et al\[[@B30]\] stated the results of 2,821,392 colonoscopies conducted over 6 years in Germany. To date, this cohort is the largest database of screening colonoscopies worldwide. The overall perforation rate in that cohort was 0.016% (439/2,821,392), including 279 (0.46/1000) patients with polypectomy and 160 patients without polypectomy (0.12/1000)\[[@B30]\]. The most significant risk factor for adverse events was a polypectomy. The frequencies of colon perforations in some larger studies (sample sizes \> 50,000 cases) published since 2000 are shown in Table [1](#T1){ref-type="table"}. The perforation rate tends to remain stable and not to change (Figure [1](#F1){ref-type="fig"}). The results of our review are consistent with a recent large-scale meta-analysis by Reumkens et al\[[@B5]\] showing that the overall perforation rate was 0.05% and the trends in the past 15 years did not show any significant change.

###### 

Summary of calculated incidence rates for perforations related to colonoscopy from recent studies with sample sizes \> 50,000 cases *n* (%)

  **Ref.**                       **Duration of enrollment**   **Study design (data source)**                                                                                    **Publication year**   **Country**      **Colonoscopies performed**   **Perforation rate (%)**
  ------------------------------ ---------------------------- ----------------------------------------------------------------------------------------------------------------- ---------------------- ---------------- ----------------------------- --------------------------
  Sieg et al\[[@B27]\]           1998-1999                    Prospective study                                                                                                 2001                   Germany          82416                         4 (0.005)
  Iqbal et al\[[@B76]\]          1994-2000                    Retrospective study                                                                                               2005                   United States    78702                         72 (0.084)
  Rabeneck et al\[[@B77]\]       2002-2003                    Population-based cohort study                                                                                     2008                   Canada           97091                         54 (0.056)
  Iqbal et al\[[@B13]\]          1980-2006                    Retrospective review                                                                                              2008                   United States    258248                        180 (0.070)
  Bokemeyer et al\[[@B45]\]      2003-2006                    Study based on German online registry                                                                             2009                   Germany          269144                        55 (0.020)
  Crispin et al\[[@B45]\]        2006                         Study based on compulsory health insurance (CHI)                                                                  2009                   Germany          236087                        69 (0.029)
  Warren et al\[[@B47]\]         2001-2005                    Population-based, matched cohort study.                                                                           2009                   United States    53220                         33 (0.062)
  Arora et al\[[@B72]\]          1995-2005                    Population-based cohort study                                                                                     2009                   United States    277434                        228 (0.082)
  Rabeneck et al\[[@B78]\]       2002-2003                    Population-based cohort study                                                                                     2011                   Canada           67632                         37 (0.055)
  Pox et al\[[@B30]\]            2003-2008                    Prospective cross-sectional study                                                                                 2012                   Germany          2821392                       439 (0.016)
  Hamdani et al\[[@B73]\]        2002-2010                    Retrospective cross-sectional study                                                                               2013                   United States    80118                         50 (0.062)
  Samalavicius et al\[[@B79]\]   2007-2011                    Retrospective multicenter study                                                                                   2013                   Lithuania        56882                         40 (0.070)
  Blotière et al\[[@B29]\]       2010                         Study based on comprehensive French health insurance data (SNIIRAM)                                               2014                   France           947061                        424 (0.045)
  Rutter et al\[[@B52]\]         2006-2012                    Study based on English National Health Service Bowel Cancer Screening Program (NHSBCSP)                           2014                   United Kingdom   130831                        20 (0.015)
  Zafar et al\[[@B48]\]          2007-2008                    Health Insurance Portability and Accountability Act compliant study                                               2014                   United States    54039                         46 (0.085)
  Bielawska et al\[[@B16]\]      2000-2011                    Prospectively collected data from the Clinical Outcomes Research Initiative (CORI) National Endoscopic Database   2014                   Canada           1144900                       192 (0.017)
  Shi et al\[[@B34]\]            2000-2012                    Retrospective study                                                                                               2014                   China            110785                        14 (0.012)

![Yearly trends of perforation rates.](WJG-25-190-g001){#F1}

Most of the studies about post-colonoscopy perforations were performed in the West, whereas relatively few studies have been conducted in the East\[[@B31]\]. In addition, the numbers of subjects participating in the studies were significantly lower than in the West. Teoh et al\[[@B31]\] showed that the overall perforation rate is 0.113%, and revealed a decreasing trend between 1998 and 2005 in China. Unlike other studies, interestingly, perforation in this study occurred more in diagnostic colonoscopies than in therapeutic colonoscopies. In Taiwan, lower colonoscopy-related perforation rates have been reported at 0-0.065%\[[@B32],[@B33]\]. A recent retrospective study in China reported on 110,785 colonoscopies analyzed during a 12 year period. As a result, 14 perforations (0.012%) occurred\[[@B34]\]. We used data from the National Health Insurance Service (NHIS) of the Republic of Korea to identify the incidence rate of colonoscopy perforations in 2011 (unpublished data). According to our results, 14 patients had perforations among 31,177 colonoscopies (0.045%). Taken together, colonoscopy-related perforation rates are not significantly different between the East and West. More importantly, the perforation probability after colonoscopy does not decrease over time in either the West or the East.

BLEEDING TIME TRENDS AND REGIONAL DIFFERENCES
=============================================

Bleeding is one of the most common complications of colonoscopy, accounting for 0.3-6.1% of cases\[[@B35],[@B36]\]. The definition of post-colonoscopy bleeding was somewhat different among studies: lower GI bleeding after colonoscopy with/without polypectomy requiring a transfusion of packed red blood cells, hospitalization, emergency room visit, or need for repeat colonoscopy in the setting of hematochezia\[[@B5],[@B9],[@B10],[@B37]\]. Generally, immediate bleeding was defined as that occurring within 1 d after an endoscopic procedure, and delayed bleeding as that occurring from 24 h to 14 d after an endoscopic procedure\[[@B8],[@B37],[@B38]\]. Bleeding after a diagnostic endoscopy is very rare. If it occurs, it is typically associated with biopsy. This may occur when the blood vessel structure is directly biopsied, especially in patients with abnormal blood coagulation function\[[@B39]\]. It is also rarely seen in cases of severe mechanical friction due to the endoscope. According to Kavic et al\[[@B39]\], the incidence of hemorrhage during a diagnostic colonoscopy is only 0.03% (26/101,397), most of which occurs after the biopsy.

Bleeding after a polypectomy is known to occur more frequently and can be divided into immediate bleeding and delayed bleeding according to the time of onset\[[@B35],[@B36]\]. The post-polypectomy bleeding rate (0.98%) is significantly higher compared with when a polypectomy is not performed (0.06%) (*P* \< 0.001)\[[@B5]\]. The mechanism of post-polypectomy bleeding varies depending on polyp morphology. In the case of pedunculated polyps, a large feeding vessel usually passes through the stalk. Insufficient electrocoagulation during stalk cutting with a snare may cause pulsatile bleeding\[[@B40]\]. In the case of sessile polyps, the polypectomy section is usually deep and wide, which may result in insufficient electrocoagulation of the interior, resulting in bleeding from the internal margin of the section. In addition, exposed vessels are often located in the submucosal layer, which may increase the risk of delayed bleeding\[[@B41],[@B42]\]. The number, size, morphology, and histology of polyps, as well as cardiovascular disease, are risk factors for post-polypectomy bleeding\[[@B8]\]. Shalman et al\[[@B43]\] reported that use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) does not increase the risk of post-polypectomy bleeding. A recent meta-analysis showed that aspirin and NSAIDs are risk factors for delayed, but not immediate, post-polypectomy bleeding\[[@B44]\]. Table [2](#T2){ref-type="table"} summarizes the risk factors associated with post-polypectomy bleeding.

###### 

Summary of related risk factors for post-polypectomy bleeding\[[@B36],[@B41],[@B51],[@B80]-[@B84]\]

  **Patient-related factors**                                                **Polyp-related factors**   **Procedure-related factors**
  -------------------------------------------------------------------------- --------------------------- -------------------------------------------------
  Old age                                                                    Polyp size                  Cutting mode
  Anticoagulants                                                             Morphology of polyps        Bowel preparation
  Cardiovascular disease                                                     Histology                   Inadvertent cold polypectomy
  Chronic vascular disease                                                   Number of resected polyps   Endoscopist's experience
  Clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs                               Resection method Use of prophylactic hemostasis

Relatively few large-scale studies on bleeding have been reported, particularly before 2000, because it is difficult to define meaningful bleeding compared with a perforation in a large data set. Sieg et al\[[@B27]\] published the incidence of bleeding in 82,416 colonoscopies conducted in Germany from 1998 to 1999. The rate of significant hemorrhage in that prospective study was 0.001%. This is a very low complication rate. That study only targeted outpatients, and most of the endoscopies were performed by highly skilled endoscopists, thus leading to a low incidence rate of bleeding. Two large studies of more than 200,000 patients in Germany were reported in 2009\[[@B45],[@B46]\]. A total of 269,144 colonoscopies, among screening colonoscopies performed on asymptomatic patients, were collected in an online registry\[[@B45]\]. In that study, 0.164% (442/269,144) of cases reported bleeding, and the incidence of bleeding increased to 0.8% when a polypectomy was performed. However, most bleeding was treated by endoscopy, and surgical treatment was rarely required. Another study on outpatients reported a bleeding rate of 0.220% (520/236,087)\[[@B46]\]. It has also been demonstrated that male gender, increasing age, non-screening purposes, additional procedures (biopsy or polypectomy), and the absence of sedation/analgesia are risk factors for colonoscopy-related bleeding\[[@B46]\]. Recent studies in the United States have shown a higher bleeding incidence rate\[[@B47],[@B48]\]. In a population-based, matched cohort study, serious gastrointestinal events, such as bleeding or transfusion necessity, occurred in 340 of the 53,220 colonoscopies (0.639%)\[[@B47]\]. The risk for bleeding was more than four times higher for the polypectomy group (8.7/1000 colonoscopies) than the screening group (2.1/1000 colonoscopies)\[[@B47]\]. In another study, lower gastrointestinal bleeding occurred in 371 patients among 54,039 asymptomatic patients (0.687%)\[[@B48]\]. However, in that study, bleeding risk was estimated to be higher than in other studies because all enrolled patients were elderly (\> 66 years). Table [3](#T3){ref-type="table"} shows the frequency of post-colonoscopy bleeding in some larger studies (sample sizes \> 50,000 cases) published since 2000. Figure [2](#F2){ref-type="fig"} indicates the current trends in post-colonoscopy bleeding, with bleeding rates of 0.001-0.233%.

###### 

Summary of calculated incidence rates for bleeding related to colonoscopy from recent studies with sample sizes \> 50,000 cases *n* (%)

  **Ref.**                    **Duration of enrollment**   **Study design (data source)**                                                            **Publication year**   **Country**      **Colonoscopies performed**   **Bleeding**
  --------------------------- ---------------------------- ----------------------------------------------------------------------------------------- ---------------------- ---------------- ----------------------------- --------------
  Sieg et al\[[@B27]\]        1998-1999                    Prospective study                                                                         2001                   Germany          82416                         1 (0.001)
  Rabeneck et al\[[@B77]\]    2002-2003                    Population-based cohort study                                                             2008                   Canada           97091                         137 (0.141)
  Bokemeyer et al\[[@B45]\]   2003-2006                    Study based on German online registry                                                     2009                   Germany          269144                        442 (0.164)
  Crispin et al\[[@B46]\]     2006                         Study based on compulsory health insurance (CHI)                                          2009                   Germany          236087                        520 (0.220)
  Warren et al\[[@B47]\]      2001-2005                    Population-based, matched cohort study                                                    2009                   United States    53220                         340 (0.639)
  Rabeneck et al\[[@B78]\]    2002-2003                    Population-based cohort study                                                             2011                   Canada           67632                         83 (0.123)
  Pox et al\[[@B30]\]         2003-2008                    Prospective cross-sectional study                                                         2012                   Germany          2821392                       573 (0.020)
  Blotière et al\[[@B29]\]    2010                         Study based on comprehensive French health insurance data (SNIIRAM)                       2014                   France           947061                        933 (0.099)
  Rutter et al\[[@B52]\]      2006-2012                    Study based on English National Health Service Bowel Cancer Screening Program (NHSBCSP)   2014                   United Kingdom   130831                        291 (0.222)
  Zafar et al\[[@B48]\]       2007-2008                    Health Insurance Portability and Accountability Act compliant study                       2014                   United States    54039                         371 (0.687)
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Similar to perforations, studies on complications associated with bleeding have rarely been performed in the East. Several studies have recently been published, however the number of patients is smaller than those in the West\[[@B37],[@B40],[@B49]-[@B51]\]. It is also difficult to generalize because these studies targeted patients in specific situations. Ng et al\[[@B49]\] reported no adverse events (bleeding or perforation) in 4,539 colonoscopies. Studies on bleeding have been published in Korea\[[@B37],[@B40],[@B50],[@B51]\], and all of them report rates \> 1%. Kim et al\[[@B51]\] showed that a total of 9,336 colonic polyps were removed, and 262 (2.806%) polyps present with immediate post-polypectomy bleeding. In this study, age ≥ 65 years, concurrent cardiovascular or renal disease, use of anticoagulation, large polyp (≥ 1 cm), morphology of polyp, poor bowel preparation, cutting mode, and inadvertent cutting were significant risk factors for post-polypectomy bleeding\[[@B51]\]. However, those studies were only conducted on post-polypectomy bleeding. It is thus inappropriate to apply this incidence rate directly to screening colonoscopies in the East. Using our unpublished data mentioned above, we confirmed an overall incidence rate of bleeding in colonoscopies of 1.119% (349/31,177) in Korea. In our study, we analyzed the data using NHIS codes. Therefore, the incidence of bleeding was higher because all minor bleeding events were included. Recent Western studies have reported bleeding rates in 0.020-0.687% of colonoscopies\[[@B29],[@B30],[@B48],[@B52]\], and these results were two times less than those published in the East. It is unclear whether this difference is a real gap or a result of limitations in studies published in the East. In the future, well-designed large prospective studies on colonoscopy-related bleeding are needed in the East.

ADVERSE EVENTS IN SPECIFIC SITUATIONS AND MORTALITY
===================================================

Post-polypectomy syndrome (PPS) is defined as the progress of abdominal pain, leukocytosis, fever, and localized peritonitis without radiographic evidence of colonic perforation\[[@B53]\]. PPS arises after colonoscopic polypectomy with electrocoagulation. The incidence of PPS is reported to vary from 0.003-0.1%\[[@B54]\]. However, PPS after ESD occurs in about 9% of cases, which is higher than that after polypectomy or endoscopic mucosal resection\[[@B55]\]. The risk factors for PPS are hypertension, large lesions, and non-polypoid lesions\[[@B56]\]. The protective effects of submucosal injections against PPS is unclear\[[@B57]\]. Generally, PPS should be conservatively managed with medical therapy (NPO status, IV fluids, and broad-spectrum antibiotics), because the prognosis is good in the majority of cases. In rare cases, however, surgical treatment may be necessary if there is a clear perforation with diffuse peritoneal signs\[[@B55]\].

The rate of bacteremia related to colonoscopy was 0-25%, and it was not associated with infectious complications\[[@B58]\]. Only one study has evaluated the risk of bacteremia after colonoscopy in non-bleeding cirrhotic patients\[[@B59]\]. Llach et al\[[@B60]\] reported that 6 of 58 cirrhotic patients who underwent colonoscopy were culture-positive. All detected organisms were members of the normal skin flora, and all patients were asymptomatic. This result demonstrates that colonoscopy does not induce bacteremia in cirrhotic patients, and that routine use of prophylactic antibiotics is not required\[[@B60]\]. Very rarely, continuous ambulatory peritoneal dialysis after colonoscopy with or without polypectomy may occur\[[@B61],[@B62]\]. The International Society for Peritoneal Dialysis guidelines suggest antibiotic prophylaxis prior to colonoscopy. However, this recommendation is not supported by randomized controlled studies\[[@B63]\]. Bowel preparation (particularly with oral sodium phosphate (OSP)) may induce disorders of renal function and electrolytes\[[@B64]\]. In a large nationwide study, the adjusted OR for acute renal failure associated with the use of OSP was 3.7 (95%CI: 2.37-5.67) within 1 wk. Other studies have also reported that hyperphosphatemia occurs in small individuals (including lowrisk and well-hydrated patients) after administration of standard doses of OSP, and that this is related to body weight\[[@B65],[@B66]\]. In South Korea, prescribing OSP for bowel preparation is illegal. We therefore strongly recommend not using OSP for the purpose of bowel preparation.

The number of elderly patients is rising significantly. Therefore, the need for colonoscopies will increase in the aged population. However, few studies have been conducted on the safety aspects of elderly patients related to colonoscopy. Lippert et al\[[@B67]\] showed that colonoscopy is safe and feasible in elderly patients, although the complication rate (perforation rate: 0.408% (3/735), bleeding rate: 0.136% (1/735)) increases slightly in elderly patients compared with the generally recognized complication rates in younger patients. Another study evaluated the complication rates of colonoscopy in patients ≥ 90 years old compared with those 75-79 years of age\[[@B3]\]. The group of patients \> 90 years showed a higher overall complication rate, and most of the complications were cardiopulmonary events. However, the yield for advanced neoplasia and cancer increased significantly compared to the 75-79 year old patients. Therefore, it is more important to judge gains and losses due to colonoscopy in extremely elderly patients. According to a meta-analysis, the incidence rates for perforation and bleeding in patients ≥ 65 years old are 1.0/1000 colonoscopies and 6.3/1000 colonoscopies, respectively\[[@B9]\]. In particular, octogenarians have a greater chance of a perforation (1.5/1000 colonoscopies). Endoscopists must know precisely how many colonoscopy-related adverse events actually occur in elderly patients. Ultimately, practitioners must balance the risks, benefits, and costs of colonoscopy in elderly patients.

Inflammatory bowel diseases (IBDs) are chronic and progressive inflammatory diseases. Colonoscopy is a key modality for diagnosis, differential diagnosis, treatment, and predicting the prognosis of IBDs\[[@B68]\]. A systematic review study indicated that major complications were reported in 2% of patients with IBD who underwent therapeutic endoscopy\[[@B69]\]. Navaneethan et al\[[@B70]\] conducted a population-based study designed to estimate the risk of post-colonoscopy perforations in patients with IBD. The perforation rate was 1% (344/33,732) in the IBD group and 0.6% (3,658/578,458) in the control group (*P* = 0.0001). The risk of perforations was also significantly higher in the IBD group than that of the control group (adjusted odds ratio (OR): 1.83; 95% confidence interval (CI): 1.40-2.38).

The overall risk of colonoscopy-related complications increases when sedative drugs are used\[[@B71]\]. In that study, use of anesthesia was related to a 13% increase in the risk of short-term complications (ORs of hemorrhage: 1.28 (CI: 1.27-1.30) and of abdominal pain: 1.07 (CI: 1.05-1.08)). The risk of perforation increases only in patients undergoing a polypectomy (OR: 1.26 (CI: 1.09-1.52))\[[@B71]\]. However, it is unclear whether anesthesia is the cause of colonoscopy-related complications. Another study showed that non-gastroenterologist endoscopists are a risk factor for early colonoscopy perforations\[[@B16]\]. In this large study, non-gastroenterologists had higher rates of perforations than in colonoscopies conducted by gastroenterologists (OR: 2.00 (CI: 1.30-3.08)). Unlike a previous study\[[@B71]\], the use of sedative drugs did not significantly increase the perforation risk\[[@B16]\].

The incidence of mortality after a colonoscopy is very small. In a 2016 review, the mortality rate ranged from 0.007-0.07%\[[@B8]\]. In another meta-analysis, the mortality rate was 2.9/100,000 (95%CI: 1.1-5.5), and mortality rates have remained stable for the past 15 years\[[@B5]\]. However, these rates include all indications, so they cannot be applied equally to screening and surveillance colonoscopies. The most frequent colonoscopy-related complication that causes mortality is a perforation. The overall mortality rate was 25.6% among those who underwent surgical treatment after a colonoscopy perforation\[[@B31]\]. Another study reported a mortality rate of 7%\[[@B13]\]. Strong predictors of mortality are ASA class ≥ 3 and the presence of anti-platelet therapy\[[@B31]\].

DISCUSSION
==========

Large-scale studies can provide more comprehensive information on post-colonoscopy complications. In singleinstitution studies, the number of subjects is small and only specific indications, such as polypectomy, are evaluated. However, population-based research using national data has the advantage of enabling unbiased conclusions to be reached.

We summarized the incidence of post-colonoscopy complications according to colonoscopy indication and procedure (Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}). Table [4](#T4){ref-type="table"} shows the post-colonoscopy perforation rates stratified by colonoscopy indication and procedure type. The rate of perforation in screening/surveillance colonoscopy was 0.010-0.067%. However, the rate of perforation in symptomatic/diagnostic colonoscopy was 0.022-0.268%. Arora et al\[[@B72]\] reported the incidence and risk of colonic perforation according to colonoscopy indication. In this study, 22% of all colonoscopies were conducted for screening purposes (58,457/269,712). The identification of diarrhea and obstruction as indications for a colonoscopy was related to a higher incidence of perforation (0.140% and 0.374%, respectively) compared with screening colonoscopy (0.067%)\[[@B72]\]. Another study involved a subgroup analysis according to colonoscopy indication\[[@B16]\]. Of the total of 1,144,443 colonoscopies, 544,474 were for screening or surveillance. The perforation rate was 0.011% in the screening/surveillance group and 0.022% in the symptomatic/surveillance group. ASA class IV/V was most significantly associated with an increased risk of perforation in the screening/surveillance group\[[@B16]\]. Hamdani et al\[[@B73]\] showed that the incidence of perforation in a diagnostic colonoscopy group was 20-fold that of the screening colonoscopy group. A recent large-scale study analyzing health insurance data showed that the risk of perforation is significantly increased for emergency colonoscopy (OR: 4.63, CI: 3.52-6.10)\[[@B29]\]. The aforementioned large-scale studies showed that the incidence of complications is lower for screening/surveillance colonoscopies than for other indications. A recent meta-analysis also indicated that the incidence of complications varies according to indication\[[@B5]\]. In general, screening or surveillance populations tend to be less likely to require additional procedures because they have a higher percentage of health status.

###### 

Perforation rates per colonoscopy indication and procedure type from recent studies with sample sizes \> 50,000 cases (%)

  **Ref.**                    **Indication**   **Procedure**           
  --------------------------- ---------------- --------------- ------- -------
  Sieg et al\[[@B27]\]        \-               \-              0.005   0.063
  Crispin et al\[[@B46]\]     0.040            0.030           \-      \-
  Warren et al\[[@B47]\]      0.056            0.050           0.052   0.070
  Arora et al\[[@B72]\]       0.067            0.086           0.077   0.077
  Pox et al\[[@B30]\]         0.016            \-              0.012   0.046
  Hamdani et al\[[@B73]\]     0.010            0.268           0.010   0.037
  Rutter et al\[[@B52]\]      0.063            \-              0.031   0.091
  Bielawska et al\[[@B16]\]   0.011            0.022           \-      \-

###### 

Bleeding rates per colonoscopy indication and procedure type from recent studies with sample sizes \> 50,000 cases (%)

  **Ref.**                  **Indication**   **Procedure**           
  ------------------------- ---------------- --------------- ------- -------
  Sieg et al\[[@B27]\]      \-               \-              0.001   0.270
  Crispin et al\[[@B46]\]   0.240            0.210           \-      \-
  Warren et al\[[@B47]\]    0.206            0.375           0.336   0.874
  Pox et al\[[@B30]\]       0.020            \-              0.001   0.092
  Rutter et al\[[@B52]\]    0.647            \-              0.102   1.136

Unlike perforation, few large-scale studies have assessed the incidence of bleeding by colonoscopy indication (Table [5](#T5){ref-type="table"}). Two studies together analyzed more than 50,000 colonoscopies and reported the incidence of bleeding according to colonoscopy indication. Crispin et al\[[@B46]\] reported similar rates of bleeding in screening and symptomatic colonoscopy groups (0.240% *vs* 0.210%); however, the OR was higher in the symptomatic group (1 (reference) *vs* 1.312 (1.042-1.655)). Warren et al\[[@B47]\] showed that the rate of bleeding after colonoscopy was higher in the diagnostic group than the screening group (0.206% *vs* 0.375%). The risk per 1000 persons of post-colonoscopy bleeding was also similar (2.1 *vs* 3.7). In another meta-analysis, the symptomatic group had a higher bleeding rate than the screening/surveillance group (2.4 (0.9-4.6) *vs* 4.6 (0.1-15.8), *P* \< 0.001)\[[@B5]\].

Polypectomy also affects the incidence of perforation. According to six large-scale studies, the rate of perforation for polypectomy was 0.037-0.091%, compared to 0.005-0.077% for colonoscopy without polypectomy (Table [4](#T4){ref-type="table"})\[[@B27],[@B30],[@B47],[@B52],[@B72],[@B73]\]. During polypectomy, perforation may occur due to grabbing of deep colonic wall layers or excessive thermal injury. The rate of complications during colonoscopy screening differs significantly depending on whether polypectomy was performed\[[@B30]\]. Polypectomy has a marked effect on the incidence of bleeding (Table [5](#T5){ref-type="table"}). The rate of post-colonoscopy bleeding in the non-polypectomy group was 0.001-0.336%, compared to 0.092-1.136% in the polypectomy group (Table [5](#T5){ref-type="table"}). Polypectomy is itself a risk factor for bleeding. In addition, the polyp size, morphology, and number (risk factors for post-polypectomy bleeding) exert a synergistic effect on the risk of bleeding.

To date, diverse risk factors for colonoscopic perforation and bleeding have been identified. Patient-related factors (old age, female gender, multiple comorbidities, large polyps) and the need for additional intervention such as polypectomy are among these risk factors\[[@B14],[@B16]\]. Three studies have evaluated the risk factors for post-colonoscopy bleeding\[[@B5],[@B8],[@B9]\], which are listed in Table [6](#T6){ref-type="table"}. Polypectomy, polyp size, and old age are common risk factors for post-colonoscopy perforation and bleeding in several studies.

###### 

Summary of major risk factors for perforation and bleeding related to colonoscopy from recent studies with sample sizes \> 50,000 cases (%)

  **Ref.**                       **Risk factors for perforation**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Risk factors for bleeding**
  ------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Rabeneck et al\[[@B77]\]       Comorbidity score ≥ 3 (OR: 3.73, 95%CI: 1.59-8.77), Polypectomy (OR: 2.96, 95%CI: 2.31-3.80), Old age (OR: 2.06, 95%CI: 1.79-2.37)                                                                                                                                                                                                                                                                                                                                                                               Polypectomy (OR: 10.32, 95%CI: 6.52-16.34), Old age (OR: 1.61, 95%CI: 1.20-2.16)
  Crispin et al\[[@B46]\]        Polyp size: 0.5-1 cm (OR: 11.93, 95%CI: 3.02-47.13), Polyp size: 1-3 cm (OR: 28.12, 95%CI: 7.82-101.09), Polyp size \> 3 cm (OR: 31.49, 95%CI: 6.37-155.66), Polypectomy (OR: 2.27, 95%CI: 1.39-3.70), Old age (OR: 1.00, 95%CI: 1.00-1.00)                                                                                                                                                                                                                                                                      Polyp size: 0.5-1 cm (OR: 5.25, 95%CI: 3.42-8.06), Polyp size: 1-3 cm (OR: 16.84, 95%CI: 11.14-25.46), Polyp size \> 3 cm (OR: 27.52, 95%CI: 17.20-44.05), Polypectomy (OR: 60.21, 95%CI: 35.90-100.99), Biopsy (OR: 8.88, 95%CI: 5.06-15.59), Colonoscopy in patients with symptoms (OR: 1.31, 95%CI: 1.04-1.67), Pedunculated polyp (OR: 1.55, 95%CI: 1.26-1.90), Number of polyps: 2-4 (OR: 1.26, 95%CI: 1.06-1.50), Old age (OR: 1.00, 95%CI: 1.00-1.00)
  Arora et al\[[@B72]\]          Colonoscopy indication (obstruction) (OR: 5.09, 95%CI: 3.17-8.20), Colonoscopy procedure[1](#T6FN1){ref-type="table-fn"} (OR: 6.12, 95%CI: 3.16-11.83), Comorbidity score ≥ 2 (OR: 1.52, 95%CI: 1.12-2.06), Old age (OR: 1.01, 95%CI: 1.00-1.02)                                                                                                                                                                                                                                                                 \-
  Pox et al\[[@B30]\]            Polypectomy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Polypectomy
  Hamdani et al\[[@B73]\]        Colonoscopy indication: Crohn's disease (OR: 5.16, 95%CI: 1.79-14.88), Colonoscopy indication: abdominal pain (OR: 5.79, 95%CI: 2.64-12.74), Colonoscopy indication : Diagnostic (OR: 15.33, 95%CI: 7.79-30.18), Inpatient (OR: 11.05, 95%CI: 5.14-23.75), ICU patient (OR: 5.83, 95%CI: 2.80-12.14), Low albumin (≤ 4.0) (OR: 3.58, 95%CI: 1.72-7.47), Old age (OR: 1.03, 95%CI: 1.01-1.05)                                                                                                                     \-
  Samalavicius et al\[[@B79]\]   Low-volume practice center                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \-
  Blotière et al\[[@B29]\]       Age: 60-69 (OR: 2.91, 95%CI: 1.66-5.10), Age: 70-79 (OR: 5.38, 95%CI: 3.08-9.40), Age ≥ 80 (OR: 7.51, 95%CI: 4.20-13.45), Emergency colonoscopy (OR: 4.63, 95%CI: 3.52-6.10), Polyp size ≥ 1 cm (OR: 2.72, 95%CI: 2.05-3.60)                                                                                                                                                                                                                                                                                     Age: 60-69 (OR: 1.70, 95%CI: 1.18-2.43), Age: 70-79 (OR: 2.55, 95%CI: 1.77-3.66), Age ≥ 80 (OR: 3.23, 95%CI: 2.21-4.73), Emergency colonoscopy (OR: 5.99, 95%CI: 5.01-7.15), Polyp size ≥ 1 cm (OR: 5.12, 95%CI: 4.33-6.04), Chronic disease (OR: 1.76, 95%CI: 1.53-2.02), Gender (male) (OR: 1.64, 95%CI: 1.43-1.87)
  Rutter et al\[[@B52]\]         Polypectomy, Location of polyp (cecum) (OR: 5.60, 95%CI: 1.37-22.83)                                                                                                                                                                                                                                                                                                                                                                                                                                             Polypectomy, Location of polyp (cecum) (OR: 13.50, 95%CI: 3.93-46.42), Increasing polyp size (OR: 4.92, 95%CI: 2.84-8.51)
  Bielawska et al\[[@B16]\]      Age: 60-74 (OR: 2.69, 95%CI: 1.83--3.98), Age ≥ 75 (OR: 5.63, 95%CI: 3.73-8.49), Gender (female) (OR: 2.00, 95%CI: 1.43-2.80), ASA class III (OR: 2.14, 95%CI: 1.22-3.75), ASA class IV/V (OR: 7.20, 95%CI: 2.41-21.50), Hospital setting: university (OR: 2.83, 95%CI: 1.85-4.31), Hospital setting: VA/military (OR: 3.74, 95%CI: 2.37-5.89), Any therapy (OR: 3.93, 95%CI: 2.05-7.56), Polyp size ≥ 1 cm (OR: 4.14, 95%CI: 2.58-6.65), Endoscopy specialty: surgery or unknown (OR: 2.00, 95%CI: 1.30-3.08)   \-

Colonoscopy procedure includes treatment of foreign-body, submucosal injection, hemostasis, endoscopic ultrasound, transmural or intramural aspiration or biopsy.

CHALLENGES
==========

Many clinical and national studies have identified adverse events during colonoscopy procedures. Although the rate of adverse events is low, it should not be underestimated. In particular, perforations are associated with high rates of morbidity and mortality. They can also cause serious conditions in healthy people. Another concern is the occurrence of a chain effect caused by the complication. An adverse event not only affects the patient the moment it occurs, but also afterwards. A rise in the complication rate is expected to increase the frequency of hospitalization, follow-up, and total costs. In addition, as more colonoscopies are performed, the number of procedures, such as polypectomy, will also increase, which will increase the probability of complications. These impacts may be greater at the national level. Therefore, it is important to accurately understand the occurrence of colonoscopy-related complications and to improve the rates in routine clinical practice.

Population-based cohort studies and large data-based studies are expected to provide more realistic information on colonoscopy complications. However, some points to be overcome in the future should be discussed. First, there is a likelihood that adverse events are under-reported, as reports of complications may be self-reported by the practitioner. In some cases, an adverse event may not be recorded correctly because the occurrence of complications can be disputed by the practitioner. In addition, if complications are not listed in the health insurance data, they will not be included in the overall incidence calculation. Therefore, the actual incidence of colonoscopy-related adverse events may be higher than reported. Second, many different colonoscopy indications have been revealed in different studies. Although there is a clear difference in the incidence rates of adverse events between screening/surveillance and polypectomy, the indications are not clearly distinguished in each study. In particular, it is often difficult to clearly distinguish these indications in large-scale research using big data because many data sources are mixed. Third, it is difficult to evaluate the mortality of each complication because various treatment methods have been applied for the same complication. Finally, most studies did not apply consistent definitions for an adverse event. This review article is limited by the use of different definitions of immediate and delayed bleeding among the included studies. In particular, there is a significant difference among studies that define post-colonoscopy complications with regard to when they occurred after the procedure (≤ 7 d, ≤ 14 d, or ≤ 30 d).

The exact study of post-colonoscopy complications is very difficult. To do this, a transparent reporting or monitoring system should be introduced. Therefore, the ASGE and ESGE guidelines recommend adverse events related to colonoscopy reporting as a longitudinal quality indicator of colonoscopy\[[@B74],[@B75]\]. More importantly, accurate record of predictive factors associated with post-colonoscopy complications, unified checking systems after inspection, unit-specific web-based input systems for monitoring of short-term and long-term complications (depending on region, country or insurance company), and prospectively data accumulation systems should be established. In addition, a large-scale prospective study is needed to improve the prevention of post-colonoscopy complication through these monitoring systems.

CONCLUSION
==========

In this review, we have highlighted recent global trends in colonoscopy-related adverse events. Despite the increasing number of colonoscopy trials solving technical difficulties, there has been no significant change in the incidence of post-colonoscopy complications (particularly perforations and bleeding), and a small number of complications are constantly occurring. It is crucial to use a consistent definition and refined data worldwide to identify and compare adverse events in the future. Future studies should use a uniform definition for post-colonoscopy complications. When complications occur, standardized systems and recording methods are required to enable structured monitoring and reviewing (type of complication, cause of occurrence, and treatment method). In addition, the recording and monitoring systems mentioned in the preceding challenges section should also be actively introduced. There is an inevitable part where adverse events like perforation can occur stochastically, regardless of the experience of the procedure. We should therefore share responsibility for these complications. These methods will improve quality indicators of the practitioner and help to institute a systematic national management program. In addition, introducing structured training programs for endoscopists is needed. If these processes are well established, we will be able to set a better national policy direction for colonoscopy, improve clinical outcomes and, ultimately, reduce patient risk in the future\[[@B76]-[@B84]\].
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